Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Analgesia · Postoperative Pain · HRTX

Heron Therapeutics

Heron Therapeutics patent portfolio — 46 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
100 Regency Forest Dr, Cary, North Carolina 27518, US HQ
1983 Founded
188 Employees
Public company Type
HRTX · NYSE Ticker
Company details
Status
Public
HQ
100 Regency Forest Dr, Cary, North Carolina 27518, US
Founded
1983
Employees
188
Programs
18
Drugs
17
Patents
46
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Patents

Heron Therapeutics patents

46 pharmaceutical patents indexed for Heron Therapeutics. 0 expire within 24 months.

Heron Therapeutics has 46 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

46 patents

Patent portfolio

  1. US 12318376

    Compositions of a polyorthoester and an aprotic solvent

    Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12290520

    Methods of use of emulsion formulations of aprepitant

    Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12115254

    Methods of use of emulsion formulations of an NK-1 receptor antagonist

    Expires Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12115255

    Methods of use of emulsion formulations of an NK-1 receptor antagonist

    Expires Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11878074

    Methods of use of emulsion formulations of an NK-1 receptor antagonist

    Expires Mon Jan 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11844837

    Compositions of a polyorthoester and an organic acid excipient

    Expires Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11744800

    Methods of use of emulsion formulations of an NK-1 receptor antagonist

    Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11413350

    Long-acting polymeric delivery systems

    Expires Mon Aug 11 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11253504

    Compositions of a polyorthoester and an aprotic solvent

    Expires Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11173118

    Emulsion formulations of an NK-1 receptor antagonist and uses thereof

    Expires Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11083730

    Long-acting polymeric delivery systems

    Expires Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11083797

    Long-acting polymeric delivery systems

    Expires Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10980886

    Compositions of a polyorthoester and an organic acid excipient

    Expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10953018

    Emulsion formulations of aprepitant

    Expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10898575

    Long-acting polymeric delivery systems

    Expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 10835514

    Dry powder inhaler compositions of 7-azoniabicyclo[2.2.1]heptane derivatives

    Expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10632199

    Long-acting polymeric delivery systems

    Expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10624850

    Emulsion formulations of an NK-1 receptor antagonist and uses thereof

    Expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10500208

    Emulsion formulations of aprepitant

    Expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10398686

    Compositions of a polyorthoester and an aprotic solvent

    Expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 10357570

    Methods of treating nausea utilizing semi-solid delivery vehicle compositions comprising granisetron

    Expires Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 10213510

    Long-acting polymeric delivery systems

    Expires Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 10098957

    Long-acting polymeric delivery systems

    Expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9974742

    Emulsion formulations of an NK-1 receptor antagonist and uses thereof

    Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9974794

    Emulsion formulations of aprepitant

    Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9974793

    Emulsion formulations of aprepitant

    Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9913910

    Methods of treating nausea utilizing semi-solid delivery vehicle compositions comprising granisetron

    Expires Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9913909

    Compositions of a polyorthoester and an aprotic solvent

    Expires Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9808465

    Emulsion formulations of aprepitant

    Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9801945

    Long-acting polymeric delivery systems

    Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9744163

    Compositions of a polyorthoester and an aprotic solvent

    Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9694079

    Long-acting polymeric delivery systems

    Expires Mon Jun 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9592227

    Compositions of a polyorthoester and an aprotic solvent

    Expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9561229

    Emulsion formulations of aprepitant

    Expires Mon Feb 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9446036

    Compositions of a polyorthoester and an aprotic solvent

    Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9320731

    7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof

    Expires Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9315568

    Cadherin-11 EC1 domain antagonists for treating inflammatory joint disorders

    Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8952067

    Subcutaneous fat reduction

    Expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8940300

    Humanized antibodies targeting the EC1 domain of Cadherin-11 and related compositions and methods

    Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8742131

    7-azoniabicyclo [2.2.1] heptane derivatives, methods of production, and pharmaceutical uses thereof

    Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8742134

    7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof

    Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8715710

    Semi-solid delivery vehicle and pharmaceutical compositions for delivery of granisetron

    Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8697633

    Dissolution of arterial plaque

    Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8426611

    7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof

    Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8304383

    Dissolution of arterial plaque

    Expires Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 6057421

    Variable heavy and light chain regions of murine monoclonal antibody 1F7

    Expires Mon Apr 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Heron Therapeutics have?

46 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Heron Therapeutics patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.